Literature DB >> 21632100

Correlation between LRIG1 and LRIG2 expressions and expression of 11 tumor markers, with special reference to tumor suppressors, in CIN and normal cervical epithelium.

A K Lindström1, A Asplund, D Hellberg.   

Abstract

OBJECTIVE: Novel biological markers LRIG1 and LRIG2 have been associated with favorable as well as poor prognosis, respectively, in different cancer types, including cervical cancer. The aim of this study was to investigate possible interactions between these proteins and other tumor markers, and as diagnostic adjuncts in CIN.
METHODS: Cervical biopsies from 171 women, with normal epithelium, and low-grade and high-grade CIN were stained for LRIG1 and LRIG2, and 11 additional tumor markers. The tumor markers were chosen to be relevant in cervical neoplasms. Staining was evaluated semiquantitatively.
RESULTS: Expression of LRIG1 and LRIG2 was found to correlate with increasing CIN grade, as well as with expression of tumor suppressor FHIT, independent of histological grade. In addition, tumor promoter LRIG2 expression correlated negatively with expression of tumor suppressor retinoblastoma protein and positively with IL-10. The latter correlation did not however remain after adjustment for CIN grade. p53 and p16 expressions correlated positively with LRIG1 expression in univariate analyses, but significance did not hold after adjustment for CIN grade.
CONCLUSION: LRIG1 and LRIG2 expressions were seen in precancerous cervical epithelium and found to increase with increasing grade. There was an association between expression of these glycoproteins and FHIT tumor suppressor protein, independently of histological grade.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21632100     DOI: 10.1016/j.ygyno.2011.04.049

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  5 in total

1.  Transcription factor co-localization patterns affect human cell type-specific gene expression.

Authors:  Dennis Wang; Augusto Rendon; Willem Ouwehand; Lorenz Wernisch
Journal:  BMC Genomics       Date:  2012-06-21       Impact factor: 3.969

2.  Expression of LRIG proteins as possible prognostic factors in primary vaginal carcinoma.

Authors:  Cecilia Ranhem; Gabriella Lillsunde Larsson; Håkan Hedman; David Lindquist; Mats G Karlsson; Ann-Cathrin Hellström; Ellinor Östensson; Bengt Sorbe; Kristina Hellman; Sonia Andersson
Journal:  PLoS One       Date:  2017-08-25       Impact factor: 3.240

3.  Downregulation of LRIG2 expression inhibits angiogenesis of glioma via EGFR/VEGF-A pathway.

Authors:  Hong-Kuan Yang; Hao Chen; Feng Mao; Qun-Gen Xiao; Rui-Fan Xie; Ting Lei
Journal:  Oncol Lett       Date:  2017-07-26       Impact factor: 2.967

4.  Immunohistochemical LRIG3 expression in cervical intraepithelial neoplasia and invasive squamous cell cervical cancer: association with expression of tumor markers, hormones, high-risk HPV-infection, smoking and patient outcome.

Authors:  A K Lindström; D Hellberg
Journal:  Eur J Histochem       Date:  2014-04-15       Impact factor: 3.188

5.  LRIG2 expression and prognosis in non-small cell lung cancer.

Authors:  Guangchuan Wang; Jie Wu; Huijuan Song
Journal:  Oncol Lett       Date:  2014-05-19       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.